Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Pascal Defaye
Added diagnostic value of Electrophysiological study in new-onset Left Bundle Branch Block after transcatheter aortic valve implantation
Keyword LBBB TAVI Conduction disorders electrophysiological study Get full text access Log in, subscribe or purchase for full access. References 1. Massoullié, G. ∙ Ploux, S. ∙ Souteyrand, G. ... Incidence and management of atrioventricular conduction disorders in new-onset left bundle branch block after TAVI: A prospective multicenter study Heart Rhythm. 2023; S1547-5271 00032-2 2. Nijenhuis, V.J. ∙ Van Dijk, V.F. ∙ Chaldoupi, S.M. ...
Cardiac implantable electronic devices’ longevity: A novel modelling tool for estimation and comparison
Loading metrics Open Access Peer-reviewed Research Article Citation: Defaye P, Boveda S, Billuart J-R, Witte KK, Paton MF (2025) Cardiac implantable electronic devices’ longevity: A novel modelling tool for estimation and comparison. PLoS One 20(9): e0333195.
Cardiac Implantable Electronic Devices longevity: A novel modelling tool for estimation and comparison.
P.D. receives grants and honoraria from Medtronic, Boston Scientific, Abbott, and Microport S.B. is a consultant for Medtronic, Boston Scientific, Microport. JRB is an employee of Microport CRM who supervised Maxime Corneloup as an intern. KKW has received research funding from the British Heart Foundation, the National Institute for Health Research, the Medical Research Council.
Khaldoun G Tarakji
Khaldoun Tarakji, MD, is the Chief Medical Officer VP Clinical Research and Medical Science of the Cardiac Ablation Solutions (CAS) Operating Unit (OU) at Medtronic. Before joining Medtronic, Khaldoun was the Associate Section Head of Cardiac Electrophysiology in the Department of Cardiovascular Medicine, Heart, Vascular & Thoracic Institute at Cleveland Clinic.
Pre‐emptive treatment of heart failure exacerbations in patients managed with the HeartLogic™ algorithm
Introduction Heart failure (HF) affects >50 million people worldwide and is associated with significant morbidity1 and a mortality in excess of 40% 5 years after diagnosis.2 HF is associated with a high readmission rate, which is estimated to be 25% within the first 30 days after diagnosis,3 accounts for 1 to 2% of all hospitalizations and is the major economic burden related to HF.4 Remote monitoring of patients with HF is a promising development which may enable treatment of subclinical HF...
Outcomes Associated With Left Atrial Appendage Occlusion Via Implanted Device in Atrial Fibrillation
Abstract To compare outcomes after left atrial appendage occlusion (LAAO) via implanted device vs no LAAO in a matched cohort of patients with atrial fibrillation (AF). This longitudinal retrospective cohort study was based on the national database covering hospital care for the entire French population. Adults (≥18 years of age) who had been hospitalized with AF (January 1, 2015, to January 1, 2020) who underwent LAAO were identified.
Optimal Management of Cardiac Implantable Electronic Device Infections – Dr Bruce Wilkoff
Skip to main content Video Published: Views: 42 Likes: 0 Average (ratings) Find out what your colleagues are talking about, tune in to our Optimal Management of Cardiac Implantable Electronic Device Infections podcast! Renowned industry experts explore what CIED infections mean for you and your patients. Find out why antibiotics alone do not work and what you can do. Plus, watch our unmissable patients stories episode. This series is supported by Related content
Gestion optimale des infections liées aux dispositifs électroniques cardiaques implantables - Prof Pascal Defaye
Video Published: Views: 36 Likes: 0 Average (ratings) Pour savoir de quoi vos collègues discutent, soyez à l'écoute de notre podcast «Gestion Optimale des Infections des Dispositifs Électroniques Implantables Cardiaques (CIED)» ! Des experts renommés de l’industrie explorent les conséquences des infections CIED pour vous et vos patients. Découvrir pourquoi il ne suffit pas d’utiliser seulement des antibiotiques, et ce que vous pouvez faire.
A Dual-Chamber Leadless Pacemaker
Abstract Background Single-chamber ventricular leadless pacemakers do not support atrial pacing or consistent atrioventricular synchrony. A dual-chamber leadless pacemaker system consisting of two devices implanted percutaneously, one in the right atrium and one in the right ventricle, would make leadless pacemaker therapy a treatment option for a wider range of indications.
Acute procedural efficacy and safety of a novel cryoballoon for the treatment of paroxysmal atrial fibrillation: Results from the POLAR ICE study
ORIGINAL ARTICLE Claire A. Martin and Roland R. R. Tilz are cofirst authors. Disclosures: C. A. M.: Speaker fees and research grants from BSCI and Medtronic, speaker fees from Biosense Webster. P. D.: Honoraria and research grants from Boston Scientific, Medtronic, Abbott, and Microport CRM. A.
Healthcare costs in implantable cardioverter-defibrillator recipients: A real-life cohort study on 19,408 patients from the French national healthcare database
Highlights • About two thirds of the healthcare expenses of implantable cardioverter-defibrillator (ICD) recipients are not directly related to the device • An ICD costs about €5000/patient-year (including implantation hospital stay, ICD follow-up, complications if any, and replacement if any) • The implantation hospital stay incurs the highest proportion (around 60%), then replacement (around 20%), complications (around 10%) and follow-up (around 10%) of the ICD-related costs Abstract...
Benefits of left ventricular endocardial pacing comparing failed implants and prior non-responders to conventional cardiac resynchronization therapy: A subanalysis from the ALSYNC study
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. FiguresFig. 1Panel A: Kaplan–Meier estimated mortality. At 24 months, mortality was 17.2% in failed CS implants and 22.8% in prior non-responders, with a HR of 1.54 estimated from Cox regression (95% confidence interval [CI] 0.65–3.65; p = .32).Panel B: Average LVESVi at different visits. Error bars represent 1 standard deviation.Panel C: LVEF at different visits.
Percutaneous Left Atrial Appendage Closure Is a Reasonable Option for Patients With Atrial Fibrillation at High Risk for Cerebrovascular Events
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00 Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
Permanent form of junctional reciprocating tachycardia in adults: peculiar features and results of radiofrequency catheter ablation
Abstract Aim PJRT occurs predominantly in infants and children and is limited to small series in adults. The aim of this study was to describe the clinical presentation, electrophysiological characteristics, feasibility and safety of radiofrequency ablation, and the long-term prognosis in a large group of adult patients with the permanent form of junctional reciprocating tachycardia (PJRT).
Results from a multicentre comparison of cryoballoon vs. radiofrequency ablation for paroxysmal atrial fibrillation: is cryoablation more reproducible? | EP Europace
Aim Cryoballoon ablation (Cryoballoon) has emerged as a new alternative for the treatment of symptomatic drug-refractory atrial fibrillation (AF). Whether the results of Cryoballoon are more reproducible than those of radiofrequency (RF) ablation remains to be proved.
Primary Prevention Implantable Cardioverter Defibrillator (ICD) Therapy in Women-Data From a Multicenter French Registry
|
Methods and Results Using a large multicenter cohort of consecutive patients referred for ICD implantation for primary prevention (2002–2012), in ischemic and nonischemic cardiomyopathy, we examined the sex differences in subjects' characteristics and outcomes. Of 5539 patients, only 837 (15.1%) were women and 53.8% received cardiac resynchronization therapy.
By Rui Providência, Eloi Marijon, Pier D. Lambiase, Didier Klug, Abdeslam Bouzeman, Pascal Defaye, Denis Amet, Marie‐Cécile Perier, Daniel Gras, Vincent Algalarrondo, Jean‐Claude Deharo, Christophe Leclercq, Laurent Fauchier, Dominique Babuty, Pierre Bordachar, Nicolas Sadoul, Olivier Piot, Serge Boveda
|
jaha.ahajournals.org
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Pascal
Contact Pascal, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack